EVIDENCE GENERATION: IDENTIFYING AND ADDRESSING GAPS TO MEET THE CLINICAL AND EDUCATIONAL NEEDS OF STAKEHOLDERS
posterposted on 25.02.2018 by Ian Greenway, Maria Vander Sande
Poster sessions are particularly prominent at academic conferences. Posters are usually one frame of a powerpoint (or similar) presentation and are represented at full resolution to make them zoomable.
Objectives: To provide a clear framework that enables a thorough situational and behavioral analysis to be conducted to identify evidence gaps in the clinical development plan that may become a barrier to effective product use by health-care professionals. To understand the range of options available to address these key evidence gaps, and how to effectively and efficiently implement a compelling evidence-generation plan early in a product’s development that will support all key stakeholders’ educational needs throughout its life cycle.
Challenge/problem: Situation analyses and their subsequent interpretation are often conducted in an inconsistent manner and do not always take into account deep insights into the behavioral and cultural environment of health-care professionals and their patients. This can leave vital gaps in a product’s evidence base. Coupled with this, evidence-generation planning is often highly reactive. As a result, medical plans are not always grounded in the right evidence to address key stakeholder needs through the life cycle and may lack a consistent thread from medical strategy through to communication tactics.
Solution: To develop a framework for comprehensive and robust evidence platform generation, with its translation into actions that drive positive behavioral change in health care through engaging and creative multichannel delivery.
Outcome: A medical plan that ensures valuable evidence is anticipated, in place, and linked to a clear end goal of positive behavioral change in patient care. Benefits: Starting a formal evidence-generation and communication process early in development (i.e. Phase 2) ensures that the necessary information is available to make pricing, reimbursement, and product-positioning decisions at the time of launch.